Speakers

Joachim Koch

Head Translational Reseach & Innovaiton

Affimed GmbH

Peter Flynn

CTO

Artiva Biotherapeutics Inc.

Stewart Abbot

CSO

Adicet Bio

Allen Feng

CSO

HebeCell Corp.

Emily Mace

Assistant Proffesor

Columbia University in the City of New York

Noah Merin

Professor

Cedars-Sinai Medical Centre

Robin Parihar

Assistant Proffesor

Baylor College of Medicine

Amy Sharma

Project Lead Scientist, Development

Genentech Inc.

Bob Valamehr

CDO

Fate Therapeutics

Martha Elia Luevano Salinas

Global Product Manager Innate Lymphocytes

Miltenyi Biotec

Alice Brown

VP of Research

GammaDelta Therapeutics

Daniel Teper

CEO

Cytovia Therapeutics

Amir Horowitz

Professor

Icahn School of Medicine at Mount Sinai

Evren Alici

CEO

Vycellix

Larry Lamb

CSO

Incysus

Dean Lee

Director, Cellular Therapy and Cancer Immunotherapy

Nationwide Children's Hospital

Elie Haddad

Professor of Paediatrics

University of Montreal

Jeffrey Miller

Professor

University of Minnesota

Michael O’Dwyer

Professor

NUI Galway

Alaina Schlinker

Senior Manager, Cell Therapy Application Support

Fresenius Kabi

Nick Huntington

CSO

oNKo-Innate Pty Ltd

Silke Paust

Associate Professor

Scripps Institute

Alicja Copik

Research Assistant Professor

University of Central Florida

Anahid Jewett

Professor

University of California Los Angeles

Dan Kaufman

Professor

University of California

Luis Borges

CSO

Century Therapeutics

James Trager

CSO

Nkarta Therapeutics

Robert Igarashi

VP, Discovery & Pre-Clinical Development

Kiadis Pharma

Todd Fehniger

Associate Professor

Washington University School of Medicine in St Louis

Gabriella Perell

Product Manager, Cell & Gene Therapy

Bio-Techne

Will Singleterry

Director, Scientific Collaborations

IsoPlexis

John Veluchamy

Senior Scientist, Development

Glycostem